Zlatković-Švenda, M.; Ovuka, M.; Ogrič, M.; Čučnik, S.; Žigon, P.; Radivčev, A.; Zdravković, M.; Radunović, G.
Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19. Biomedicines 2023, 11, 3117.
https://doi.org/10.3390/biomedicines11123117
AMA Style
Zlatković-Švenda M, Ovuka M, Ogrič M, Čučnik S, Žigon P, Radivčev A, Zdravković M, Radunović G.
Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19. Biomedicines. 2023; 11(12):3117.
https://doi.org/10.3390/biomedicines11123117
Chicago/Turabian Style
Zlatković-Švenda, Mirjana, Milica Ovuka, Manca Ogrič, Saša Čučnik, Polona Žigon, Aleksandar Radivčev, Marija Zdravković, and Goran Radunović.
2023. "Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19" Biomedicines 11, no. 12: 3117.
https://doi.org/10.3390/biomedicines11123117
APA Style
Zlatković-Švenda, M., Ovuka, M., Ogrič, M., Čučnik, S., Žigon, P., Radivčev, A., Zdravković, M., & Radunović, G.
(2023). Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19. Biomedicines, 11(12), 3117.
https://doi.org/10.3390/biomedicines11123117